Synata Bio Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 25

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $606K

  • Investors
  • 1

Synata Bio General Information

Description

Developer of a fermentation technology designed to process synthesis gas from multiple sources into products. The company's technology is a non-GMO biocatalyst that harmonizes all feedstocks with carbon utilization and an efficient gas-to-liquids platform, enabling chemical companies to have access to a sustainable technology to produce primary alcohols.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Industrial Chemicals
Other Industries
Environmental Services (B2B)
Primary Office
  • 4575 Weaver Parkway
  • Suite 100
  • Warrenville, IL 60555
  • United States
+1 (312) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synata Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 01-Feb-2021 $606K Completed Startup
3. Buyout/LBO 19-Oct-2020 0000 Completed Startup
2. Early Stage VC (Series A) 30-Jan-2018 $30M $77M 0000 Completed Startup
1. Early Stage VC 11-Apr-2017 $47M $47M Completed Startup
To view Synata Bio’s complete valuation and funding history, request access »

Synata Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Synata Bio’s complete cap table history, request access »

Synata Bio Patents

Synata Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200199519-A1 System and method for concentrating suspended solids prior to removal Pending 31-Jul-2017 000000000
AU-2018309697-A1 System and method for concentrating suspended solids prior to removal Inactive 31-Jul-2017 000000000
CA-3071542-A1 System and method for concentrating suspended solids prior to removal Pending 31-Jul-2017 000000000
AU-2017382765-A1 Methods and systems using ionophores to control contamination in fermentation of gaseous substrates Inactive 22-Dec-2016 000000000
CA-3047764-A1 Methods and systems using ionophores to control contamination in fermentation of gaseous substrates Pending 22-Dec-2016 C12P7/065
To view Synata Bio’s complete patent history, request access »

Synata Bio Executive Team (5)

Name Title Board Seat Contact Info
Macy Stoneback Executive Officer
Steve Sloma Vice President of Finance & Commercial Development
Steven Kloos Ph.D President & Board Member
Jeremy Patt Ph.D Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

Synata Bio Board Members (5)

Name Representing Role Since
Alan Henderson Synata Bio Board Member 000 0000
Jay Kouba Ph.D True North Venture Partners Board Member 000 0000
Matthew Ahearn True North Venture Partners Board Member 000 0000
Michael Ahearn JD True North Venture Partners Chairman 000 0000
Steven Kloos Ph.D Self President & Board Member 000 0000
To view Synata Bio’s complete board members history, request access »

Synata Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synata Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
True North Venture Partners Venture Capital Minority 000 0000 000000 0
To view Synata Bio’s complete investors history, request access »

Synata Bio Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 05-Dec-2016 0000000000 000.00 Energy Production
Abengoa Bioenergy Biomass (Hugoton cellulosic ethanol plant) 30-Nov-2016 Corporate Asset Purchase 000.00 Buildings and Property
To view Synata Bio’s complete investments and acquisitions history, request access »